WuXi Biologics
Search results
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients.
WuXi AppTec provides R&D & manufacturing services enabling companies in the pharmaceutical & biotech industries worldwide to advance discoveries.
WuXi AppTec ( WuXi is pronounced as Wu-shee) is a global pharmaceutical, biopharmaceutical, and medical device company.
Jun 12, 2024 · After months of sharp share-price declines, WuXi AppTec and WuXi Biologics enjoyed a brief respite Wednesday amid new uncertainties about the legislative path of the BIOSECURE Act.
May 15, 2024 · U.S. legislation that would restrict business with China's BGI, WuXi AppTec and certain other biotech companies on national security grounds was approved by a U.S. House of Representatives ...
Mar 28, 2024 · U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property to Beijing...
Apr 30, 2024 · With WuXi AppTec’s very existence under threat from proposed biosecurity legislation in the U.S., the Chinese CDMO giant is standing its ground on its quest to preserve its business and “do...
As an integrated #testing platform across the full life cycle of discovery and development, WuXi Testing, one of the key business segments of WuXi AppTec, provides "end-to-end" testing...
Apr 29, 2024 · As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and...
Mar 19, 2024 · That seems to be the strategy being embraced at CDMO WuXi AppTec, which issued a surprisingly upbeat 2024 forecast Monday despite concerns stemming from a national-security-related crackdown in...
